SABCS 2025

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

Kazia Therapeutics (NASDAQ: KZIA) unveils immune-boosting effects of paxalisib in advanced breast cancer at SABCS 2025

Find out how Kazia Therapeutics’ paxalisib is breaking new ground in breast cancer immunotherapy. Read the latest clinical insights from SABCS 2025.

bySrinath

December 10, 2025

ATNM-400 from Actinium Pharmaceuticals (ATNM) shows breakthrough promise in resistant breast cancer

Actinium’s ATNM-400 shows potent activity in resistant breast cancer and TNBC. Find out what the new SABCS 2025 data reveal about this radiopharma candidate.

byVenkatesh

December 1, 2025

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

Kazia Therapeutics (NASDAQ: KZIA) unveils immune-boosting effects of paxalisib in advanced breast cancer at SABCS 2025

ATNM-400 from Actinium Pharmaceuticals (ATNM) shows breakthrough promise in resistant breast cancer

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

WSP Global raises Arcadis takeover offer to €51.50 as engineering consolidation accelerates

Wall Street welcomes Repligen’s $1.5bn BioLife deal, but integration now matters

Popular’s CEO is retiring after 14 months. Why investors should watch the CFO taking over

Renishaw plc (LSE: RSW) beats upgraded guidance with £815m full-year revenue